JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CVSA
2326
Covista Inc
CVSA
$4.2B
| $7.26M | ﹤0.01% |
201,899
+21,035
| +12% | +$663K |
2013 Q2
36 quarters
|
|
|
CNR
2327
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $7.26M | ﹤0.01% |
296,455
-657,111
| -69% | -$16M |
2016 Q2
24 quarters
|
|
2328
CALL
West Pharmaceutical
WST
$25.7B
| $7.26M | ﹤0.01% |
+24,000
| New | +$7.81M |
2022 Q2
0 quarters
|
|
2329
Insmed
INSM
$23.7B
| $7.22M | ﹤0.01% |
366,244
+254,542
| +228% | +$5.33M |
2013 Q2
36 quarters
|
|
|
TDCX
2330
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $7.22M | ﹤0.01% |
780,182
+181,703
| +30% | +$2.1M |
2021 Q4
2 quarters
|
|
2331
TechnipFMC
FTI
$27B
| $7.21M | ﹤0.01% |
1,071,242
-1,359,040
| -56% | -$10.4M |
2013 Q2
36 quarters
|
|
2332
PUT
Philip Morris
PM
$293B
| $7.21M | ﹤0.01% |
73,000
-29,900
| -29% | -$3.05M |
2021 Q4
2 quarters
|
|
2333
Ambarella
AMBA
$3.1B
| $7.2M | ﹤0.01% |
110,016
-1,369
| -1% | -$110K |
2015 Q4
26 quarters
|
|
2334
JetBlue
JBLU
$1.57B
| $7.2M | ﹤0.01% |
859,782
-223,097
| -21% | -$2.39M |
2014 Q3
31 quarters
|
|
|
LDHA
2335
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
| $7.2M | ﹤0.01% |
736,484
+603,484
| +454% | +$5.91M |
2021 Q4
2 quarters
|
|
2336
Stewart Information Services
STC
$1.55B
| $7.18M | ﹤0.01% |
144,331
-250,274
| -63% | -$13.4M |
2013 Q2
36 quarters
|
|
2337
Doximity
DOCS
$5.08B
| $7.17M | ﹤0.01% |
205,840
-1,557,352
| -88% | -$61.3M |
2021 Q2
4 quarters
|
|
|
ILPT
2338
Industrial Logistics Properties Trust
ILPT
$465M
| $7.15M | ﹤0.01% |
507,828
+39,483
| +8% | +$648K |
2018 Q1
17 quarters
|
|
|
PMT
2339
PennyMac Mortgage Investment
PMT
$677M
| $7.13M | ﹤0.01% |
515,468
+424,098
| +464% | +$6.47M |
2017 Q4
18 quarters
|
|
|
MCHB
2340
Mechanics Bancorp
MCHB
$3.28B
| $7.12M | ﹤0.01% |
205,433
-24,982
| -11% | -$1.01M |
2013 Q2
36 quarters
|
|
2341
SunCoke Energy
SXC
$827M
| $7.12M | ﹤0.01% |
1,045,686
-180,006
| -15% | -$1.45M |
2013 Q2
36 quarters
|
|
2342
CALL
Yum China
YUMC
$13.9B
| $7.12M | ﹤0.01% |
146,800
+85,000
| +138% | +$3.58M |
2021 Q1
5 quarters
|
|
2343
AngioDynamics
ANGO
$636M
| $7.12M | ﹤0.01% |
367,800
-1,515
| -0.4% | -$31K |
2016 Q1
25 quarters
|
|
2344
Spruce Power Holding Corp
SPRU
$30.4M
| $7.11M | ﹤0.01% |
773,006
-7,103
| -0.9% | -$81.8K |
2021 Q1
5 quarters
|
|
2345
SiTime
SITM
$20.4B
| $7.11M | ﹤0.01% |
43,620
+7,209
| +20% | +$1.36M |
2020 Q1
9 quarters
|
|
|
FBC
2346
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $7.11M | ﹤0.01% |
200,531
-398,952
| -67% | -$14.8M |
2013 Q2
36 quarters
|
|
|
K
2347
CALL
DELISTED
Kellanova
K
| $7.11M | ﹤0.01% |
106,074
+85,413
| +413% | +$5.55M |
2021 Q1
5 quarters
|
|
|
NGM
2348
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $7.08M | ﹤0.01% |
552,541
+18,620
| +3% | +$258K |
2019 Q2
12 quarters
|
|
2349
BancFirst
BANF
$3.58B
| $7.08M | ﹤0.01% |
73,943
-20,536
| -22% | -$1.79M |
2013 Q2
36 quarters
|
|
2350
Simply Good Foods
SMPL
$874M
| $7.08M | ﹤0.01% |
187,314
+57,386
| +44% | +$2.27M |
2017 Q4
18 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.